These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27995525)

  • 1. Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice.
    Dutta R; Kumar V; Peng Y; Evande RE; Grem JL; Mahato RI
    Pharm Res; 2017 Mar; 34(3):564-578. PubMed ID: 27995525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis.
    Kumar V; Dong Y; Kumar V; Almawash S; Mahato RI
    Theranostics; 2019; 9(25):7537-7555. PubMed ID: 31695785
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice.
    Kumar V; Mundra V; Peng Y; Wang Y; Tan C; Mahato RI
    Theranostics; 2018; 8(15):4033-4049. PubMed ID: 30128034
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis.
    Kumar V; Mondal G; Dutta R; Mahato RI
    Biomaterials; 2016 Jan; 76():144-56. PubMed ID: 26524535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer.
    Karaca M; Dutta R; Ozsoy Y; Mahato RI
    Mol Pharm; 2016 Jun; 13(6):1822-32. PubMed ID: 26981724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene glycol)-block-poly(2-methyl-2-benzoxycarbonyl-propylene carbonate) micelles for rapamycin delivery: in vitro characterization and biodistribution.
    Lu W; Li F; Mahato RI
    J Pharm Sci; 2011 Jun; 100(6):2418-29. PubMed ID: 21264854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer.
    Kumar V; Mondal G; Slavik P; Rachagani S; Batra SK; Mahato RI
    Mol Pharm; 2015 Apr; 12(4):1289-98. PubMed ID: 25679326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.
    van Beuge MM; Prakash J; Lacombe M; Post E; Reker-Smit C; Beljaars L; Poelstra K
    Pharm Res; 2011 Aug; 28(8):2045-54. PubMed ID: 21442374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells.
    Yang N; Ye Z; Li F; Mahato RI
    Bioconjug Chem; 2009 Feb; 20(2):213-21. PubMed ID: 19133717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of rat liver fibrosis by selective targeting of hepatic stellate cells using hesperidin carriers.
    Morsy MA; Nair AB
    Int J Pharm; 2018 Dec; 552(1-2):241-250. PubMed ID: 30291958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
    Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
    J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats.
    Yang J; Hou Y; Ji G; Song Z; Liu Y; Dai G; Zhang Y; Chen J
    Eur J Pharm Sci; 2014 Feb; 52():180-90. PubMed ID: 24296297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis.
    Kumar V; Kumar V; Luo J; Mahato RI
    Mol Ther; 2018 Dec; 26(12):2798-2811. PubMed ID: 30287074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis.
    Kumar V; Mundra V; Mahato RI
    Pharm Res; 2014 May; 31(5):1158-69. PubMed ID: 24249038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting.
    Liu H; Xu H; Jiang Y; Hao S; Gong F; Mu H; Liu K
    Int J Nanomedicine; 2015; 10():6395-410. PubMed ID: 26504386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles.
    Xiang L; Wang X; Jiao Q; Shao Y; Luo R; Zhang J; Zheng X; Zhou S; Chen Y
    Acta Biomater; 2023 Sep; 168():497-514. PubMed ID: 37507035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
    Thomas RG; Moon MJ; Kim JH; Lee JH; Jeong YY
    PLoS One; 2015; 10(12):e0145512. PubMed ID: 26714035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
    Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
    Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
    Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
    Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.